Profile data is unavailable for this security.
About the company
Zhaoke Ophthalmology Ltd is a China-based investment holding company principally engaged in the development, manufacturing and marketing of ophthalmic drugs. The Company’s products include innovative drugs and generic drugs. The Company ‘s products are mainly applied in five ophthalmic indications, including dry eye disease (DED), wet age-related macular degeneration (wAMD), diabetic macular edema (DME), myopia and glaucoma.
- Revenue in HKD (TTM)62.26m
- Net income in HKD-247.07m
- Incorporated2020
- Employees297.00
- LocationZhaoke Ophthalmology LtdNo. 1 Meide 3rd Road, Pearl RiverIndustrial Park, Nansha DistrictGUANGZHOU ChinaCHN
- Phone+86 2 039062888
- Websitehttps://www.zkoph.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tianda Pharmaceuticals Ltd | 384.68m | -47.26m | 404.21m | 695.00 | -- | 0.7423 | -- | 1.05 | -0.022 | -0.022 | 0.1789 | 0.2533 | 0.4341 | 2.97 | 4.46 | 445,745.10 | -5.34 | -- | -7.97 | -- | 45.83 | -- | -12.30 | -- | 0.6748 | -9.51 | 0.1536 | -- | -- | -- | -- | -- | -- | -- |
| Transcenta Holding Ltd | 24.30m | -390.25m | 413.04m | 200.00 | -- | 0.3916 | -- | 17.00 | -0.961 | -0.961 | 0.0599 | 2.43 | 0.0131 | 0.8106 | 0.5768 | 113,009.30 | -21.08 | -- | -29.77 | -- | 26.02 | -- | -1,606.19 | -- | 1.04 | -31.65 | 0.2826 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| 3D Medicines Inc | 531.90m | -489.36m | 552.56m | 193.00 | -- | 0.5989 | -- | 1.04 | -2.08 | -2.08 | 2.23 | 3.57 | 0.3746 | 4.94 | 5.79 | 2,686,367.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 462.99m | -97.58m | 702.34m | 1.14k | -- | 1.26 | -- | 1.52 | -0.1309 | -0.1309 | 0.6215 | 0.7552 | 0.3212 | 1.68 | 5.01 | 403,305.30 | -6.77 | 0.9678 | -13.96 | 1.74 | 53.18 | 51.95 | -21.08 | 2.59 | 0.526 | -2.10 | 0.4031 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.20bn | 63.06m | 736.04m | 993.00 | 11.67 | 0.4295 | 3.75 | 0.6139 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.58 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Zhaoke Ophthalmology Ltd | 62.26m | -247.07m | 770.06m | 297.00 | -- | 0.3481 | -- | 12.37 | -0.4536 | -0.4536 | 0.1142 | 4.05 | 0.0233 | 1.25 | 16.09 | 198,906.50 | -9.23 | -- | -10.51 | -- | 82.03 | -- | -396.86 | -- | 5.48 | -24.02 | 0.1114 | -- | -- | -- | 5.47 | -- | -- | -- |
| Pak Fah Yeow International Ltd | 265.21m | 96.45m | 779.10m | 101.00 | 8.08 | 1.04 | 7.51 | 2.94 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.22bn | 121.13m | 794.51m | 2.74k | 6.43 | 0.6597 | 3.39 | 0.3572 | 0.143 | 0.143 | 2.63 | 1.39 | 1.09 | 2.68 | 7.39 | 841,488.10 | 5.99 | 7.69 | 9.17 | 11.75 | 57.55 | 60.44 | 5.49 | 6.73 | 0.9033 | 213.59 | 0.1516 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 912.95m | 186.77m | 801.16m | 678.00 | 4.29 | 0.4646 | 6.39 | 0.8776 | 0.3334 | 0.3334 | 1.63 | 3.08 | 0.3574 | 2.10 | 2.94 | 1,076,590.00 | 7.31 | 7.67 | 10.25 | 10.48 | 75.46 | 78.79 | 20.46 | 20.68 | 1.62 | -- | 0.0502 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Hbm Holdings Ltd | 561.09m | 165.51m | 911.99m | 158.00 | 5.29 | 0.9157 | 4.66 | 1.63 | 0.225 | 0.225 | 0.761 | 1.30 | 0.3258 | 3.96 | 16.67 | 3,170,010.00 | 9.59 | -54.61 | 13.25 | -66.04 | 95.57 | 97.81 | 29.42 | -400.28 | 3.44 | 8.14 | 0.3502 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 1.06bn | 279.00 | 8.72 | 1.10 | 5.77 | 1.64 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
Data as of Nov 11 2024. Currency figures normalised to Zhaoke Ophthalmology Ltd's reporting currency: Hong Kong Dollar HKD
7.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 31 Jul 2024 | 35.78m | 6.55% |
| GIC Pte Ltd. (Investment Management)as of 31 Dec 2023 | 5.13m | 0.94% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 1.00m | 0.18% |
| Amundi (UK) Ltd.as of 30 Aug 2024 | 192.50k | 0.04% |
| Amundi Hong Kong Ltd.as of 30 Jun 2023 | 63.50k | 0.01% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 39.50k | 0.01% |
| Janus Henderson Investors US LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
